Fig. 1: AMT repressed the cell viability of glioma cells.
From: Amantadine against glioma via ROS-mediated apoptosis and autophagy arrest
A The CCK-8 assay was performed in glioma cells (U87, U251, U118 and C6), mouse microglia (BV2), melanoma cells (A375, SK-MEL28 and FM55P) and hepatocellular carcinoma cells (HepG2, Hep3B and Huh7) treated with indicated concentrations of AMT for 24 h (n = 3). B Analysis of EdU incorporation in U87 and U251 treated with the indicated concentrations of AMT for 24 h (n = 3). C Analysis of LDH release in supernatants of U87 and U251 cells treated as in (A) for 24 h (n = 3). D, E Representative images for colony formation and quantitative analysis of U87 and U251 cells treated as in (A) for 24 h (n = 3). Error bars indicate mean ± SD (*P < 0.05, **P < 0.01, ***P < 0.001).
